Extensive study identifies over a dozen existing drugs as potential COVID-19 therapies
E-Mail IMAGE: A researcher at Calibr, the drug discovery division of Scripps Research, working in the high-throughput screening facility used to identify potential COVID-19 therapies. view more Credit: Scripps Research June 3, 2021 - LA JOLLA, CA--Mining the worlds most comprehensive drug repurposing collection for COVID-19 therapies, scientists have identified 90 existing drugs or drug candidates with antiviral activity against the coronavirus thats driving the ongoing global pande...
Source: eurekalert.org